Skip to main content

Search result

10 hits
  1. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2016

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2016

    Updated

    The annual report from Resistance against Antivirals in Norway (RAVN) presents national surveillance data on antiviral resistance for the following viruses: Influenza virus, HIV-1, hepatitis B virus, cytomegalovirus and herpes simplex virus.
    Report
  2. Viruses monitored for resistance

    Viruses monitored for resistance

    Updated

    In Norwegian Surveillance System for Antiviral Resistance (RAVN), resistance of influenza viruses, HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), cytomegalovirus (CMV) and herpes simplex virus (HSV) are monitored. Resistance in SARS-CoV-2 will be included in the 2022 surveillance.
    Article
  3. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2013-2014

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2013-2014

    Updated

    This is the second report from Resistance against Antivirals in Norway (RAVN) about the usage of antiviral medicines and surveillance data for viral resistance for the biannual period 2013–2014.
    Report
  4. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2017

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2017

    Updated

    The annual report from Resistance against Antivirals in Norway (RAVN) presents national surveillance data on antiviral resistance for a number of viruses.
    Report
  5. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2015

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2015

    Updated

    This is the third report from Resistance against Antivirals in Norway (RAVN). The report includes antiviral medicine use and surveillance data about viral resistance for 2015.
    Report
  6. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2018

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2018

    Updated

    The annual report from Resistance against antivirals in Norway (RAVN) with national data about antiviral resistance, focusing on relevant topics related to treatment of viral infections.
    Report
  7. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2011-2012

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2011-2012

    Updated

    The 2011-2012 report includes general information about the RAVN surveillance system as well as virus resistance in Norway during the period.
    Report
  8. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2022

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2022

    Updated

    The annual report for Resistance against Antivirals in Norway (RAVN) presents Norwegian data about antiviral resistance and highlights topics linked to treatment of viral infections.
    Report
  9. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2021

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2021

    Updated

    The annual report from Resistance against Antivirals in Norway (RAVN) presents Norwegian data about antiviral resistance and covers topics related to the treatment of viral infections.
    Report
  10. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2020

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2020

    Updated

    The annual report from Resistance against Antivirals in Norway (RAVN) presents Norwegian data about antiviral resistance and covers topics related to the treatment of viral infections.
    Report